What is the appropriate management of bleeding from an arteriovenous fistula in a dialysis patient?

Management of Bleeding from an Arteriovenous Fistula

Apply direct manual pressure immediately without applying pressure until the needle is completely removed if bleeding occurs during needle removal, and do not apply pressure to the puncture site until the needle has been completely removed to prevent vein wall damage. 1

Immediate Hemorrhage Control

Active Bleeding During or After Dialysis

When bleeding occurs from an AV fistula, the priority is immediate hemorrhage control to prevent life-threatening blood loss:

• Apply gauze dressing over the needle site but do not apply pressure until the needle is completely removed 1
• Remove the needle at approximately the same angle as it was inserted (prevents dragging the needle across skin and puncturing the vein wall with the cutting edge) 1
• Once needle is removed, apply direct manual compression - this remains the gold standard 1
• If infiltration occurs after heparin administration, carefully clot the needle tract and NOT the fistula - in some cases, leave the needle in place and cannulate another site 1
• Immediately apply ice to decrease pain, size of infiltration, and bleeding time 1

Severity Assessment and Triage

Recent data shows that over one-third of AV access bleeds presenting to emergency departments are life-threatening or high-risk severity 2. The emergency severity classification includes:

• Life-threatening: 6.1%
• High-risk: 31.8%
• Urgent: 60.6%
• Semi-urgent: 1.5% 2

Common pitfall: Approximately 78.8% of bleeding episodes are postcannulation bleeds, but 18.2% are primary ulcers over the access 2. Ulcers with thin soft tissue covering or false aneurysms require urgent surgical evaluation, as 37% present with active bleeding and carry risk of life-threatening hemorrhage 3.

Emergency Department Management

Based on the most recent outcomes data 2, ED interventions should follow this hierarchy:

1. Manual pressure (37.9% of cases) - first-line
2. Suture placement (25.8%) - for persistent bleeding
3. Topical hemostatic agents (15.2%) - adjunctive measure
4. Clamp device (13.6%) - temporary measure
5. Tourniquet placement (1.5%) - last resort only

Critical point: Vascular surgery consultation should occur in approximately half of cases 2. Having an access surgeon evaluate patients in the ED results in significantly fewer related readmissions (25% vs. 2.9%, P = 0.02) and 1-year interventions (43.8% vs. 17.7%, P = 0.02) 2.

Post-Bleeding Access Management

Immediate Post-Event Care

• Rest the fistula for at least 1 treatment if infiltration occurred 1
• If resting is not possible, cannulate above the site of infiltration on next treatment 1
• If patient has a catheter, restart fistula use with 1 needle and advance to 2 needles gradually 1

Underlying Pathology Evaluation

After appropriate physical examination, fistulogram is the gold standard for evaluating the cause of bleeding complications 1. The majority (83.3%) of patients undergoing fistulograms after bleeding episodes require an intervention 2.

Key predictor: Previous endovascular intervention for fistula outflow stenosis is a significant predictor for presenting with bleeding (p = 0.031) 3. These patients require heightened surveillance.

Definitive Management Decisions

Indications for Surgical Intervention

Approximately 45.5% of patients with AV access bleeding require an intervention 2:

• 45.5% require open surgery (60% access revisions, 40% ligations)
• 54.6% require endovascular intervention 2

For ulcers over fistulas: All ulcers should undergo excision and primary skin closure. Fistula wall defects are directly repaired in 66.7% of cases. Overall fistula salvage rate is 73.08% 3.

When to Ligate the Access

Consider fistula ligation when:

• Ruptured aneurysm with significant blood loss (>7 g/dL hemoglobin drop) 4
• Ulcer with extensive fistula wall damage requiring excision 3
• Recurrent bleeding despite interventions
• 14.8% of ulcer cases ultimately require ligation 3

Temporary Access Needs

• Tunneled dialysis catheters are placed in 15.2% of hospitalized patients with AV access bleeding 2
• 41% of patients require hospital admission for further management 2
• At 1 year, 22.7% require new AV access creation 2

Prevention of Recurrent Bleeding

Anticoagulation Management

Patients receiving anticoagulation >0.35 IU/kg/session have longer bleeding times (12.75 min vs 11.75 min, P=0.008) 5. Adjust heparin dosing when feasible without compromising dialysis adequacy.

Hemostatic Adjuncts

Important caveat: Despite common use, hemostatic dressings do NOT significantly reduce compression time (12.6 min vs 12.9 min without dressing) and add approximately 164 euros/year/patient in costs 5. Manual compression remains the standard.

Exception: Topical thrombin can markedly reduce bleeding time from puncture sites, save staff time, minimize recurrent blood loss, and prolong vascular access life 6.

Follow-Up Requirements

Critical gap in care: Only 45.5% of patients achieve 6-month follow-up with an access surgeon after a bleeding episode 2. This represents a major opportunity for improvement.

• 59% of patients represent to the ED within 90 days
• 23% of readmissions are for related causes 2

Improved interdepartmental communication and close patient follow-up are essential to prevent recurrent bleeding and preserve access function 2.